Lv1
42 积分 2025-02-05 加入
Measurable residual disease intervention in AML: a new therapeutic horizon
16天前
已完结
Azacitidine–Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia
22天前
已完结
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
1个月前
已完结
A genomic and epigenomic lens into the biology of acute lymphoblastic leukaemia
2个月前
已完结
Insights into interfacial S-scheme/bulk type II dual charge transfer mechanism enabling silver oxide/N-rich carbon nitride anti-photocorrosion and enhanced photoactivity
3个月前
已完结
Electrospun PVDF/PVP Fibrous Membrane with Photocatalytic and Superhydrophilic Properties
3个月前
已完结
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia
5个月前
已完结
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
5个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts—what truly defines the disease and does it matter?
7个月前
已关闭
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
8个月前
已完结
皖公网安备34019202002308
